Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer (Q37246401)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 June 2009
edit
Language Label Description Also known as
English
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
scientific article published on 19 June 2009

    Statements

    Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer (English)
    Heather L Pulaski
    Gregory Spahlinger
    Ines A Silva
    Karen McLean
    Angela S Kueck
    R Kevin Reynolds
    George Coukos
    Jose R Conejo-Garcia
    Ronald J Buckanovich
    19 June 2009

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit